165 related articles for article (PubMed ID: 21505757)
1. Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up?
Koc G; Divrik TR; Unlu N; Bulut V; Zorlu F
Int Urol Nephrol; 2011 Dec; 43(4):1095-100. PubMed ID: 21505757
[TBL] [Abstract][Full Text] [Related]
2. The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer.
Fenton DW; Verma S; Venner P; Sawhney R; Mackey JR
J Urol; 2002 Nov; 168(5):1971-4. PubMed ID: 12394687
[TBL] [Abstract][Full Text] [Related]
3. Fasting plasma lipid measurements following cisplatin chemotherapy in patients with germ cell tumors.
Ellis PA; Fitzharris BM; George PM; Robinson BA; Atkinson CH; Colls BM
J Clin Oncol; 1992 Oct; 10(10):1609-14. PubMed ID: 1328549
[TBL] [Abstract][Full Text] [Related]
4. Hypercholesterolemia after chemotherapy for testis cancer.
Raghavan D; Cox K; Childs A; Grygiel J; Sullivan D
J Clin Oncol; 1992 Sep; 10(9):1386-9. PubMed ID: 1325540
[TBL] [Abstract][Full Text] [Related]
5. [Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy].
Fernández-Miranda C; Schoebel N; Angulo A; Paz-Ares L; Lianes P; del Palacio A
Rev Clin Esp; 1997 Jul; 197(7):490-3. PubMed ID: 9411545
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer.
Gietema JA; Sleijfer DT; Willemse PH; Schraffordt Koops H; van Ittersum E; Verschuren WM; Kromhout D; Sluiter WJ; Mulder NH; de Vries EG
Ann Intern Med; 1992 May; 116(9):709-15. PubMed ID: 1558341
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
8. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
9. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
10. Serum creatinine and cholesterol levels of testicular cancer patients in long-term follow up.
Hisamatsu E; Kawai K; Hinotsu S; Miyanaga N; Shimazui T; Akaza H
Int J Urol; 2005 Aug; 12(8):751-6. PubMed ID: 16174050
[TBL] [Abstract][Full Text] [Related]
11. [Germ cell testicular tumors: understanding the kinetics of serum alpha-fetoprotein (AFP) during chemotherapy].
Riedinger JM; Eche N; Chevreau C; Fargeot P
Ann Biol Clin (Paris); 2008; 66(5):523-30. PubMed ID: 18957341
[TBL] [Abstract][Full Text] [Related]
12. Intratesticular effects of cisplatin-based chemotherapy.
Dieckmann KP; Loy V
Eur Urol; 1995; 28(1):25-30. PubMed ID: 8521890
[TBL] [Abstract][Full Text] [Related]
13. The course of long-term toxicity in patients treated with cisplatin-based chemotherapy for non-seminomatous germ-cell cancer.
Petersen PM; Hansen SW
Ann Oncol; 1999 Dec; 10(12):1475-83. PubMed ID: 10643539
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
Tandstad T; Cohn-Cedermark G; Dahl O; Stierner U; Cavallin-Stahl E; Bremnes RM; Klepp O
Ann Oncol; 2010 Sep; 21(9):1858-1863. PubMed ID: 20142410
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.
Vidal AD; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
Ann Oncol; 2015 Feb; 26(2):374-7. PubMed ID: 25392157
[TBL] [Abstract][Full Text] [Related]
16. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
17. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
18. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy.
Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; de Kam ML; de Roos A; Lamb HJ; Osanto S
Acta Oncol; 2014 Mar; 53(3):351-60. PubMed ID: 23957624
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of TIP (paclitaxel, ifosfamide, cisplatin) into first-line therapy for intermediate to poor risk testicular germ cell tumors with unfavorable marker decline after initial two cycles chemotherapy: a report of three cases.
Ishioka J; Kageyama Y; Ichiyanagi N; Fukuda H; Higashi Y
Int J Urol; 2007 May; 14(5):455-7. PubMed ID: 17511735
[TBL] [Abstract][Full Text] [Related]
20. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
